ALFA FinderNSE filing, NSE: AARTIDRUGS. Summary written from the filing by ALFA Finder's alert engine.
Aarti Drugs Ltd: key numbers
- Share price
- ₹446.75
- Market cap
- ₹4,077 Cr
- Revenue (annual)
- ₹2,565 Cr
- Net profit (annual)
- ₹194.9 Cr
- P/E (TTM)
- 17.8×Sector 43.0×
- Promoter holding
- 54.07%-0.36% QoQ
- FII holding
- 2.26%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aarti Drugs Ltd
All →Aarti Drugs Business Update
Aarti Drugs disclosed that the US FDA inspected its subsidiary Pinnacle Life Science's Baddi plant on 2-6 November 2026 and issued three Form 483 observations. The company states there is no financial or operational impact.
Aarti Drugs Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue Rs 826.2 Cr (+27% YoY), EBITDA Rs 137.9 Cr (16.6% margin, +370 bps), PAT Rs 82.8 Cr (+83%). Specialty chemicals nearly doubled; formulations grew 58%.
Aarti Drugs Results Update
Aarti Drugs reports Q2 FY27 revenue of ₹828.8 Crore and PAT of ₹82.8 Crore, up 83% YoY. Results reflect record quarterly EBITDA and margin expansion.
Aarti Drugs Q2 FY27 Results: Net Profit ₹82.8 Cr, Up 83.2% YoY
Aarti Drugs Ltd reported revenue from operations of ₹826.2 Cr (+26.6% YoY) and net profit of ₹82.8 Cr (+83.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹82.8 Cr · +83.2% YoY
Aarti Drugs Board Meeting Date
Aarti Drugs Ltd intimated BSE and NSE of a board meeting on November 3, 2026, to consider audited financial results for the quarter and half year ended September 30, 2026. Trading window remains closed until 48 hours after results declaration.
Aarti Drugs Other Announcement
The company submitted its quarterly shareholding pattern as of September 30, 2026, in compliance with SEBI Listing Regulations.
Other employee stock options announcements
All →SIS Employee Stock Options
SIS Limited allotted 2,683 equity shares to employees on exercise of ESOP options. Paid-up capital rose to Rs.69.43 Crore; no issue price is disclosed.
FSN E-Commerce Ventures Employee Stock Options
FSN E-Commerce allotted 6,61,020 equity shares to employees on exercise of vested ESOPs. Issued and paid-up capital increases; no transaction price is disclosed.
One Point One Solutions Employee Stock Options
One Point One Solutions allotted 1,45,754 equity shares to employees under its ESOS 2022 at an exercise price of ₹18.85. Paid-up capital rose to ₹52.62 crore.
Au Small Finance Bank Employee Stock Options
AU Small Finance Bank allotted 1,86,955 shares on exercised ESOPs under four schemes. Paid-up capital rises accordingly, with no event value disclosed.
Hero Motors Employee Stock Options
Hero Motors allotted 64,69,399 equity shares to employees exercising ESOP-2022 options at Rs. 69.14 each. The allotment lifts paid-up capital to 46,06,84,975 shares.
PB Fintech Employee Stock Options
PB Fintech allotted 24,06,644 equity shares to employees under ESOP 2021 on 7 November 2026. Issued capital rises to Rs 93.03 Crore; shares total 46.52 crore.